why choose us

First received: June 07, 2023

Clinical Trial: Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery

Study Status: Completed

Recruit Status: RECRUITING

Condition: Pain, Postoperative

Study Type: INTERVENTIONAL


Official Title: Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE1)

Brief Summary: The purpose of this study is to identify a tolerable dose for postpartum ketamine infusion using a maximum tolerated dose (MTD) 3+3 design.A loading dose over 1 hour will be the MTD variable to be tested, as our data suggest that ketamine side effects occur with the loading dose.The investigators hypothesize that subanesthetic ketamine dose will be well tolerated and any noted side effects will be rated acceptable by postpartum women following cesarean delivery.

Read more